Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.This is an entirely free service. No payments are to be made.
Here is the latest stock price and chart of Abbott India. For more details, see the Abbott India company fact sheet and quarterly results. For a sector overview, read our pharmaceuticals sector report.
|Live BSE Quotes||Mar 24, 2017 (Close)|
|Price (Rs)4,674.45||Open (Rs) 4,754.15||High (Rs) 4,787.40||Low (Rs) 4,651.10|
|% Change-2.56||Volume 647||Value (Rs) 3,042,078||52-Week H/L 5,190.00 / 4,351.00|
|Live NSE Quotes||Mar 24, 2017 (Close)|
|Price (Rs)4,683.95||Open (Rs) 4,805.00||High (Rs) 4,805.00||Low (Rs) 4,660.00|
|% Change-2.67||Volume 2,618||Value (Rs) 12,380,586||52-Week H/L 5,049.00 / 4,353.70|
|EPS (Rs)* 138.16||P/E Ratio (x) 33.83||Market Cap (Rs m) 99,332.06||P/BV (x) 8.97|
|*Trailing 12 months earnings, excluding extraordinary / exceptional items.||BSE Sensex | CNX Nifty|
|Abbott India Share Price Chart (Rs) - 1 Year|
Quote & Graph
S&P BSE SENSEX
Most of the global financial markets ended the week on a negative note. Major global markets were cautious over the week over concerns of the Trump administration's ability to push out reforms.
Sun Pharma has announced its December quarter (3QFY17) results. The company has reported 8% YoY growth in sales and a decline of 4.7% YoY in the net profits.
Cipla has announced its results for the December quarter (1QFY17) results. The company has reported a decline of 6.4% YoY in sales while profits were down by 43.7% YoY.
Lupin has announced its 3QFY17 results. Net sales have grown by 31.5% YoY and net profits have surged by 20.7% YoY. Here is our analysis of the results.
Glenmark has announced its 3QFY16 results. The company has reported 41% YoY growth in net sales and 143.2% YoY increase in net profits. Here is our analysis of the results.
Sun Pharma has announced its September quarter (2QFY17) results. The company has reported 13.2% YoY growth in sales and a growth of 117% in the net profits. Here is our analysis of the results.More Views on News
The trend that makes a select group of bluechip stocks inherently safer even at peak index valuations.
Digital transactions have fallen since December 2016 both in value and volume terms.
Apurva breaks down the historic performance of initial public offerings in the context of D-Mart.
Markets are moving up even after the fed interest rate hike.
PersonalFN provides a prudent investment strategy to invest in mutual funds as market scales a new high.More